195 related articles for article (PubMed ID: 8986815)
1. A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11.
Mohlke KL; Nichols WC; Westrick RJ; Novak EK; Cooney KA; Swank RT; Ginsburg D
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15352-7. PubMed ID: 8986815
[TBL] [Abstract][Full Text] [Related]
2. Comparative mapping of distal murine chromosome 11 and human 17q21.3 in a region containing a modifying locus for murine plasma von Willebrand factor level.
Mohlke KL; Purkayastha AA; Westrick RJ; Ginsburg D
Genomics; 1998 Nov; 54(1):19-30. PubMed ID: 9806826
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene.
Nichols WC; Cooney KA; Mohlke KL; Ballew JD; Yang A; Bruck ME; Reddington M; Novak EK; Swank RT; Ginsburg D
Blood; 1994 Jun; 83(11):3225-31. PubMed ID: 8193357
[TBL] [Abstract][Full Text] [Related]
4. High and long-term von Willebrand factor expression after Sleeping Beauty transposon-mediated gene therapy in a mouse model of severe von Willebrand disease.
Portier I; Vanhoorelbeke K; Verhenne S; Pareyn I; Vandeputte N; Deckmyn H; Goldenberg DS; Samal HB; Singh M; Ivics Z; Izsvák Z; De Meyer SF
J Thromb Haemost; 2018 Mar; 16(3):592-604. PubMed ID: 29288565
[TBL] [Abstract][Full Text] [Related]
5. New variant of von Willebrand disease type II with markedly increased levels of von Willebrand factor antigen and dominant mode of inheritance: von Willebrand disease type IIC Miami.
Ledford MR; Rabinowitz I; Sadler JE; Kent JW; Civantos F
Blood; 1993 Jul; 82(1):169-75. PubMed ID: 8324222
[TBL] [Abstract][Full Text] [Related]
6. Characterization of von Willebrand factor gene defects in two unrelated patients with type IIC von Willebrand disease.
Gaucher C; Diéval J; Mazurier C
Blood; 1994 Aug; 84(4):1024-30. PubMed ID: 8049421
[TBL] [Abstract][Full Text] [Related]
7. Modifiers of von Willebrand factor identified by natural variation in inbred strains of mice.
Shavit JA; Manichaikul A; Lemmerhirt HL; Broman KW; Ginsburg D
Blood; 2009 Dec; 114(26):5368-74. PubMed ID: 19789385
[TBL] [Abstract][Full Text] [Related]
8. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
9. The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels.
Rydz N; Swystun LL; Notley C; Paterson AD; Riches JJ; Sponagle K; Boonyawat B; Montgomery RR; James PD; Lillicrap D
Blood; 2013 Jun; 121(26):5228-37. PubMed ID: 23529928
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic analysis of porcine von Willebrand disease: tight linkage to the von Willebrand factor locus.
Bahou WF; Bowie EJ; Fass DN; Ginsburg D
Blood; 1988 Jul; 72(1):308-13. PubMed ID: 2898953
[TBL] [Abstract][Full Text] [Related]
11. Correction of bleeding symptoms in von Willebrand factor-deficient mice by liver-expressed von Willebrand factor mutants.
Marx I; Lenting PJ; Adler T; Pendu R; Christophe OD; Denis CV
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):419-24. PubMed ID: 18187670
[TBL] [Abstract][Full Text] [Related]
12. Genetic regulation of plasma von Willebrand factor levels: quantitative trait loci analysis in a mouse model.
Lemmerhirt HL; Broman KW; Shavit JA; Ginsburg D
J Thromb Haemost; 2007 Feb; 5(2):329-35. PubMed ID: 17155961
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
Miller CH; Kelley L; Green D
Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
[TBL] [Abstract][Full Text] [Related]
14. Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis.
Nichols WC; Lyons SE; Harrison JS; Cody RL; Ginsburg D
Proc Natl Acad Sci U S A; 1991 May; 88(9):3857-61. PubMed ID: 1673793
[TBL] [Abstract][Full Text] [Related]
15. Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene.
Verweij CL; Quadt R; Briët E; Dubbeldam K; van Ommen GB; Pannekoek H
J Clin Invest; 1988 Apr; 81(4):1116-21. PubMed ID: 2895123
[TBL] [Abstract][Full Text] [Related]
16. Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations.
Millar CM; Riddell AF; Brown SA; Starke R; Mackie I; Bowen DJ; Jenkins PV; van Mourik JA
Thromb Haemost; 2008 May; 99(5):916-24. PubMed ID: 18449422
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort.
Borràs N; Garcia-Martínez I; Batlle J; Pérez-Rodríguez A; Parra R; Altisent C; López-Fernández MF; Costa Pinto J; Batlle-López F; Cid AR; Bonanad S; Cabrera N; Moret A; Mingot-Castellano ME; Navarro N; Pérez-Montes R; Marcellini S; Moreto A; Herrero S; Soto I; Fernández-Mosteirín N; Jiménez-Yuste V; Alonso N; de Andrés-Jacob A; Fontanes E; Campos R; Paloma MJ; Bermejo N; Berrueco R; Mateo J; Arribalzaga K; Marco P; Palomo Á; Castro Quismondo N; Iñigo B; Del Mar Nieto M; Vidal R; Martínez MP; Aguinaco R; Tenorio M; Ferreiro M; García-Frade J; Rodríguez-Huerta AM; Cuesta J; Rodríguez-González R; García-Candel F; Dobón M; Aguilar C; Corrales I; Vidal F
Thromb Haemost; 2020 Mar; 120(3):437-448. PubMed ID: 32135566
[TBL] [Abstract][Full Text] [Related]
18. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
19. The genetic defect of type I von Willebrand disease "Vicenza" is linked to the von Willebrand factor gene.
Randi AM; Sacchi E; Castaman GC; Rodeghiero F; Mannucci PM
Thromb Haemost; 1993 Feb; 69(2):173-6. PubMed ID: 8456430
[TBL] [Abstract][Full Text] [Related]
20. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease.
Cumming A; Grundy P; Keeney S; Lester W; Enayat S; Guilliatt A; Bowen D; Pasi J; Keeling D; Hill F; Bolton-Maggs PH; Hay C; Collins P;
Thromb Haemost; 2006 Nov; 96(5):630-41. PubMed ID: 17080221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
